TY - JOUR
T1 - Inhibition of antigen-specific IgE production by antigen coupled to membrane IgE peptide
AU - Chen, Swey Shen
AU - Schmaltz, Robert
AU - Wang, Yan Yu
AU - Kong, Qing Xian
AU - Petro, Thomas
AU - Li, Qing
AU - Chang, Tse Wen
PY - 1996
Y1 - 1996
N2 - The membrane IgE peptide (MEP) encompassing 20 amino acids proximal to the C terminus of membrane IgE molecules, and secretory IgE peptides (SEP), spanning CHε 1 to 4 domain were synthesized according to IgE genomic and cDNA sequences. Inhibition of anti-KLH and anti-BGG IgE, but not IgG responses was observed in mice treated with MEP-protein but not SEP-protein conjugates in complete/incomplete Freund's adjuvant. Only IgE responses directed toward proteins to which MEP was conjugated, were inhibited, while IgE responses to a concomitantly injected, unrelated antigen were not. Inhibition of antigen-specific IgE was also not correlated with levels of anti-MEP or anti-IgE antibodies; moreover, levels of total IgE remained comparable among mice treated with MEP-protein conjugates, native or glutaraldehyde-modified protein carriers. This observation may have significant import on future design of IgE immunotherapy. Treatment of MEP conjugated allergens prevents formation of IgE-anti-IgE complexes because the MEP sequence is absent from the secretory IgE.
AB - The membrane IgE peptide (MEP) encompassing 20 amino acids proximal to the C terminus of membrane IgE molecules, and secretory IgE peptides (SEP), spanning CHε 1 to 4 domain were synthesized according to IgE genomic and cDNA sequences. Inhibition of anti-KLH and anti-BGG IgE, but not IgG responses was observed in mice treated with MEP-protein but not SEP-protein conjugates in complete/incomplete Freund's adjuvant. Only IgE responses directed toward proteins to which MEP was conjugated, were inhibited, while IgE responses to a concomitantly injected, unrelated antigen were not. Inhibition of antigen-specific IgE was also not correlated with levels of anti-MEP or anti-IgE antibodies; moreover, levels of total IgE remained comparable among mice treated with MEP-protein conjugates, native or glutaraldehyde-modified protein carriers. This observation may have significant import on future design of IgE immunotherapy. Treatment of MEP conjugated allergens prevents formation of IgE-anti-IgE complexes because the MEP sequence is absent from the secretory IgE.
UR - http://www.scopus.com/inward/record.url?scp=0029854915&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029854915&partnerID=8YFLogxK
U2 - 10.3109/08820139609055738
DO - 10.3109/08820139609055738
M3 - Article
C2 - 8915686
AN - SCOPUS:0029854915
SN - 0882-0139
VL - 25
SP - 495
EP - 505
JO - Immunological Investigations
JF - Immunological Investigations
IS - 5-6
ER -